Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Aequorin Based Functional Assessment of the Melanin Concentrating Hormone Receptor by Intracellular Calcium Mobilization

  • Lee, Sung-Hou (Department of Biomedical Technology, Sangmyung University)
  • Received : 2010.03.24
  • Accepted : 2010.04.02
  • Published : 2010.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Melanin concentrating hormone is a neuropeptide highly expressed in the brain that regulates several physiological functions mediated by receptors in the G-protein coupled receptor family, especially plays an important role in the complex regulation of energy balance and body weight mediated by the melanin concentrating hormone receptor subtype 1 (MCH1). Compelling pharmacological evidence implicating MCH1 signaling in the regulation of food intake and energy expenditure has generated a great deal of interest by pharmaceutical companies as MCH1 antagonists may have potential therapeutic benefit in the treatment of obesity and metabolic syndrome. Although fluorescence-based calcium mobilization assay platform has been one of the most widely accepted tools for receptor research and drug discovery, fluorescence interference and shallow assay window limit their application in high throughput screening and have led to a growing interest in alternative, luminescence-based technologies. Herein, a luminescence-based functional assay system for the MCH1 receptor was developed and validated with the mitochondrial targeted aequorin. Aequorin based functional assay system for MCH1 presented excellent Z' factor (0.8983) and high signal-to-noise ratio (141.9). The nonpeptide MCH1 receptor antagonist, SNAP 7941 and GSK 803430, exhibited $IC_{50}$ values of 0.62 ${\pm}$ 0.11 and 12.29 ${\pm}$ 2.31 nM with excellent correlation coefficient. These results suggest that the aequorin based assay system for MCH1 is a strong alternative to the traditional GPCR related tools such as radioligand binding experiments and fluorescence functional determinations for the compound screening and receptor research.

Keywords

References

  1. Bachner, D., Kreienkamp, H., Weise, C., Buck, F. and Richter, D. (1999). Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1). FEBS Lett. 457, 522-524. https://doi.org/10.1016/S0014-5793(99)01092-3
  2. Bittencourt, J. C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J. L., Vale, W. and Sawchenko, P. E. (1992). The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol. 319, 218-245. https://doi.org/10.1002/cne.903190204
  3. Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Lagu, B., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Blackburn, T. P., Branchek, T. A., Gerald, C., Vaysse, P. J. and Forray, C. (2002). Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. 8, 825-830. https://doi.org/10.1038/nm741
  4. Bovolenta, S., Foti, M., Lohmer, S. and Corazza, S. (2007). Development of a Ca(2+)-activated photoprotein, Photina, and its application to high-throughput screening. J. Biomol. Screen 12, 694-704. https://doi.org/10.1177/1087057107301497
  5. Brough, S. J. and Shah, P. (2009). Use of aequorin for G protein-coupled receptor hit identification and compound profiling. Methods Mol. Biol. 552, 181-198. https://doi.org/10.1007/978-1-60327-317-6_13
  6. Burbaum, J. J. and Sigal, N. H. (1997). New technologies for high-throughput screening. Curr. Opin. Chem. Biol. 1, 72-78. https://doi.org/10.1016/S1367-5931(97)80111-1
  7. Chaki, S., Yamaguchi, J., Yamada, H., Thomsen, W., Tran, T. A., Semple, G. and Sekiguchi, Y. (2005). ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety. CNS Drug Rev. 11, 341-352.
  8. Chambers, J., Ames, R. S., Bergsma, D., Muir, A., Fitzgerald, L. R., Hervieu, G., Dytko, G. M., Foley, J. J., Martin, J., Liu, W. S., Park, J., Ellis, C., Ganguly, S., Konchar, S., Cluderay, J., Leslie, R., Wilson, S. and Sarau, H. M. (1999). Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400, 261-265. https://doi.org/10.1038/22313
  9. David, D. J., Klemenhagen, K. C., Holick, K. A., Saxe, M. D., Mendez, I., Santarelli, L., Craig, D. A., Zhong, H., Swanson, C. J., Hegde, L. G., Ping, X. I., Dong, D., Marzabadi, M. R., Gerald, C. P. and Hen, R. (2007). Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl} (4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J. Pharmacol. Exp. Ther. 321, 237-248.
  10. Dupriez, V. J., Maes, K., Le Poul, E., Burgeon, E. and Detheux, M. (2002). Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors. Recept. Channels 8, 319-330. https://doi.org/10.1080/10606820214646
  11. Georgescu, D., Sears, R. M., Hommel, J. D., Barrot, M., Bolanos, C. A., Marsh, D. J., Bednarek, M. A., Bibb, J. A., Maratos-Flier, E., Nestler, E. J. and DiLeone, R. J. (2005). The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci. 25, 2933-2940. https://doi.org/10.1523/JNEUROSCI.1714-04.2005
  12. Gilchrist, M. A. 2nd, Cacace, A. and Harden, D. G. (2008). Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening. J. Biomol. Screen 13, 486-493. https://doi.org/10.1177/1087057108319212
  13. Hedley, L., Phagoo, S. B. and James, I. F. (1996). Measurement of intracellular calcium in cell populations loaded with aequorin: neurokinin-1 responses in U373MG cells. Anal. Biochem. 236, 270-274. https://doi.org/10.1006/abio.1996.0166
  14. Hill, J., Duckworth, M., Murdock, P., Rennie, G., Sabido-David, C., Ames, R. S., Szekeres, P., Wilson, S., Bergsma, D. J., Gloger, I. S., Levy, D. S., Chambers, J. K. and Muir, A. I. (2001). Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J. Biol. Chem. 276, 20125-20129. https://doi.org/10.1074/jbc.M102068200
  15. Kowalski, T. J. and McBriar, M. D. (2004). Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity. Expert Opin. Investig. Drugs 13, 1113-1122. https://doi.org/10.1517/13543784.13.9.1113
  16. Kowalski, T. J., Spar, B. D., Weig, B., Farley, C., Cook, J., Ghibaudi, L., Fried, S., O'Neill, K., Del Vecchio, R. A., McBriar, M., Guzik, H., Clader, J., Hawes, B. E. and Hwa, J. (2006). Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Eur. J. Pharmacol. 535, 182-191. https://doi.org/10.1016/j.ejphar.2006.01.062
  17. Le Poul, E., Hisada, S., Mizuguchi, Y., Dupriez, V. J., Burgeon, E. and Detheux, M. (2002). Adaptation of aequorin functional assay to high throughput screening. J. Biomol. Screen 7, 57-65. https://doi.org/10.1177/108705710200700108
  18. Lembo, P. M., Grazzini, E., Cao, J., Hubatsch, D. A., Pelletier, M., Hoffert, C., St-Onge, S., Pou, C., Labrecque, J., Groblewski, T., O'Donnell, D., Payza, K., Ahmad, S. and Walker, P. (1999). The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat. Cell Biol. 1, 267-271. https://doi.org/10.1038/12978
  19. Mashiko, S., Ishihara, A., Gomori, A., Moriya, R., Ito, M., Iwaasa, H., Matsuda, M., Feng, Y., Shen, Z., Marsh, D. J., Bednarek, M. A., MacNeil, D. J. and Kanatani, A. (2005). Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice. Endocrinology 146, 3080-3086. https://doi.org/10.1210/en.2004-1150
  20. Pinilla, C., Appel, J. R., Borras, E. and Houghten, R. A. (2003). Advances in the use of synthetic combinatorial chemistry: mixture-based libraries. Nat. Med. 9, 118-122. https://doi.org/10.1038/nm0103-118
  21. Rink, T. J. (1990). Receptor-mediated calcium entry. FEBS Lett. 268, 381-385. https://doi.org/10.1016/0014-5793(90)81290-5
  22. Saito, Y., Nothacker, H. P., Wang, Z., Lin, S. H., Leslie, F. and Civelli, O. (1999). Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400, 265-269. https://doi.org/10.1038/22321
  23. Saito, Y., Wang, Z., Hagino-Yamagishi, K., Civelli, O., Kawashima, S. and Maruyama, K. (2001). Endogenous melanin-concentrating hormone receptor SLC-1 in human melanoma SK-MEL-37 cells. Biochem. Biophys. Res. Commun. 289, 44-50. https://doi.org/10.1006/bbrc.2001.5926
  24. Shearman, L. P., Camacho, R. E., Sloan Stribling, D., Zhou, D., Bednarek, M. A., Hreniuk, D. L., Feighner, S. D., Tan, C. P., Howard, A. D., Van der Ploeg, L. H., MacIntyre, D. E., Hickey, G. J. and Strack, A. M. (2003). Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eur. J. Pharmacol. 475, 37-47. https://doi.org/10.1016/S0014-2999(03)02146-0
  25. Shimazaki, T., Yoshimizu, T. and Chaki, S. (2006). Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders. CNS Drugs 20, 801-811. https://doi.org/10.2165/00023210-200620100-00002
  26. Smith, D. G., Davis, R. J., Rorick-Kehn, L., Morin, M., Witkin, J. M., McKinzie, D. L., Nomikos, G. G. and Gehlert, D. R. (2006). Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology 31, 1135-1145. https://doi.org/10.1038/sj.npp.1300913
  27. Stables, J., Green, A., Marshall, F., Fraser, N., Knight, E., Sautel, M., Milligan, G., Lee, M. and Rees, S. (1997). A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal. Biochem. 252, 115-126. https://doi.org/10.1006/abio.1997.2308
  28. Tan, C. P., Sano, H., Iwaasa, H., Pan, J., Sailer, A. W., Hreniuk, D. L., Feighner, S. D., Palyha, O. C., Pong, S. S., Figueroa, D. J., Austin, C. P., Jiang, M. M., Yu, H., Ito, J., Ito, M., Ito, M., Guan, X. M., MacNeil, D. J., Kanatani, A., Van der Ploeg, L. H. and Howard, A. D. (2002). Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics 79, 785-792. https://doi.org/10.1006/geno.2002.6771
  29. Vaughan, J. M., Fischer, W. H., Hoeger, C., Rivier, J. and Vale, W. (1989). Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125, 1660-1665. https://doi.org/10.1210/endo-125-3-1660
  30. Walstab, J., Combrink, S., Bruss, M., Gothert, M., Niesler, B. and Bonisch, H. (2007). Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization. Anal. Biochem. 368, 185-192. https://doi.org/10.1016/j.ab.2007.06.007
  31. Wang, S., Behan, J., O'Neill, K., Weig, B., Fried, S., Laz, T., Bayne, M., Gustafson, E. and Hawes, B. E. (2001). Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, mch-r2. J. Biol. Chem. 276, 34664-34670. https://doi.org/10.1074/jbc.M102601200
  32. Zhang, J. H., Chung, T. D. and Oldenburg, K. R. (1999). A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen 4, 67-73. https://doi.org/10.1177/108705719900400206